These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32500654)

  • 1. Relevance of physicochemical properties and functional pharmacology data to predict the clinical safety profile of direct oral anticoagulants.
    Ferro CJ; Solkhon F; Jalal Z; Al-Hamid AM; Jones AM
    Pharmacol Res Perspect; 2020 Jun; 8(3):e00603. PubMed ID: 32500654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database.
    Barbieri MA; Cutroneo PM; Baratelli C; Cicala G; Battaglia A; Santoro V; Andò G; Spina E
    J Clin Pharm Ther; 2021 Aug; 46(4):1027-1040. PubMed ID: 33646603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions.
    Monaco L; Biagi C; Conti V; Melis M; Donati M; Venegoni M; Vaccheri A; Motola D
    Br J Clin Pharmacol; 2017 Jul; 83(7):1532-1543. PubMed ID: 28071818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Under-reporting of gastrointestinal bleeding associated with anticoagulant use using the UK Yellow Card Scheme.
    Shuttleworth P; Baker J; Clark E
    Int J Clin Pharm; 2023 Aug; 45(4):1014-1018. PubMed ID: 37269441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance.
    Moudallel S; van den Eynde C; Malý J; Rydant S; Steurbaut S
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1143-1153. PubMed ID: 36656352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of adverse drug reactions associated with direct oral anticoagulants recorded in the Italian Pharmacovigilance Network database using a specifically developed risk index].
    Uguccioni M; Terranova A; Di Lullo L
    G Ital Cardiol (Rome); 2018 Oct; 19(10 Suppl 1):3S-11S. PubMed ID: 30281039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines.
    Gronemann C; Hause S; Assmann A; Neumann J; Schreiber S; Heinze HJ; Goertler M
    Cerebrovasc Dis; 2020; 49(4):412-418. PubMed ID: 32756054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland.
    Mueller T; Alvarez-Madrazo S; Robertson C; Wu O; Bennie M
    Br J Clin Pharmacol; 2019 Feb; 85(2):422-431. PubMed ID: 30423191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.
    Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005894. PubMed ID: 32160790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant Prescribing for Non-Valvular Atrial Fibrillation in the Veterans Health Administration.
    Rose AJ; Goldberg R; McManus DD; Kapoor A; Wang V; Liu W; Yu H
    J Am Heart Assoc; 2019 Sep; 8(17):e012646. PubMed ID: 31441364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and Predictors of Oral Anticoagulant Use in People with Alzheimer's Disease and the General Population in Australia.
    Ilomäki J; Fanning L; Keen C; Sluggett JK; Page AT; Korhonen MJ; Meretoja A; Mc Namara KP; Bell JS
    J Alzheimers Dis; 2019; 70(3):733-745. PubMed ID: 31256129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal Impairment.
    Ting C; Rhoten M; Dempsey J; Nichols H; Fanikos J; Ruff CT
    Clin Appl Thromb Hemost; 2021; 27():1076029620987900. PubMed ID: 33517715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Prevalence of Non-Valvular Atrial Fibrillation and Anticoagulation Therapy in a Japanese Region　- Analysis Using the National Health Insurance Database.
    Narita N; Okumura K; Kinjo T; Mikami J; Tsushima K; Takahashi R; Noro M; Hashimoto A; Sasaki T; Takaki M; Ishidoya E; Narita Y; Imai H; Ono E; Tomita H
    Circ J; 2020 Apr; 84(5):706-713. PubMed ID: 32213724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
    Adachi T; Hoshino H; Takagi M; Fujioka S;
    Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribers' views and experiences of using direct acting oral anticoagulants in the management of nonvalvular atrial fibrillation: A survey in remote and rural Scotland.
    Generalova D; Cunningham S; Leslie SJ; Rushworth G; McIver L; Stewart D
    Br J Clin Pharmacol; 2019 Oct; 85(10):2414-2422. PubMed ID: 31313317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
    Alamneh EA; Chalmers L; Bereznicki LR
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses.
    Briasoulis A; Gao Y; Inampudi C; Alvarez P; Asleh R; Chrischilles E; Leira EC; Vaughan-Sarrazin M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):42. PubMed ID: 32013886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Direct Oral Anticoagulants Versus Warfarin for Intracardiac Thromboses.
    Iskaros O; Marsh K; Papadopoulos J; Manmadhan A; Ahuja T
    J Cardiovasc Pharmacol; 2021 May; 77(5):621-631. PubMed ID: 33560043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.
    Elewa H; El-Makaty H; Ali Z
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):155-161. PubMed ID: 28978236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.